<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397593775</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164946.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199607  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1093/jac/38.1.39</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1093/jac/38.1.39</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[S. Ballestero, A. Fern´ndez-Rodriguez, R. Villaverde, H. Escobar, J. C. Pérez-Diaz, F. Baquero]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The evolution of imipenem resistance was evaluated in Pseudomonas aeruginosa sequentially isolated from 42 patients with cystic fibrosis. Susceptibility was determined using a commercial microdilution system and imipenem resistance was confirmed by the agar dilution technique. Resistance to imipenem increased during the years from 1988 to 1992. A total of 12 patients (28.5%) carried resistant strains (11.6% of the total P. aeruginosa isolates) but only two of them were treated with the carbapenem. The other patient under imipenem treatment did not harbour resistant isolates. Sixty-four percent of the imipenem resistant isolates were also meropenem resistant and showed low susceptibility to the other β-lactams and tobramycin and amikacin. Twenty-one strains were selected for biochemical study. Imipenem susceptible strains showed normal OprD in two strains and diminished OprD in two more. Five strains with MIC of imipenem of 4-8 mg‐L lacked OprD while another two had a band with decreased density. All strains with MIC higher than 8 completely lacked this band in western-blot analysis. Imipenem MICs of 0.5-2 mg/L only slightly increased to 1-4 mg/L when a pattern of β-lactamase derepression was observed. While those with imipenem MICs between 8-16 mg/L increased the imipenem MIC to 16-64 mg/L in the population with a β-lactamase derepression phenotype.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">© 1996 by the British Society for Antimicrobial Chemotherapy</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Original articles</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ballestero</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Fern´ndez-Rodriguez</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Villaverde</subfield>
   <subfield code="D">R.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Escobar</subfield>
   <subfield code="D">H.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Pérez-Diaz</subfield>
   <subfield code="D">J. C.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Baquero</subfield>
   <subfield code="D">F.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Journal of Antimicrobial Chemotherapy</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">38/1(1996-07), 39-45</subfield>
   <subfield code="x">0305-7453</subfield>
   <subfield code="q">38:1&lt;39</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">38</subfield>
   <subfield code="o">jac</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1093/jac/38.1.39</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">other</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1093/jac/38.1.39</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ballestero</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Fern´ndez-Rodriguez</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Villaverde</subfield>
   <subfield code="D">R.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Escobar</subfield>
   <subfield code="D">H.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Pérez-Diaz</subfield>
   <subfield code="D">J. C.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Baquero</subfield>
   <subfield code="D">F.</subfield>
   <subfield code="u">Servicios de Microbiología y Pediatría, Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Crta Colmenar Viejo km 9,100. 28034 Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Journal of Antimicrobial Chemotherapy</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">38/1(1996-07), 39-45</subfield>
   <subfield code="x">0305-7453</subfield>
   <subfield code="q">38:1&lt;39</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">38</subfield>
   <subfield code="o">jac</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
